Top Markets
Coin of the day
Gentian Diagnostics AS Gentian Diagnostics AS

Gentian Diagnostics AS

GENT
Pozycja w akcjach #24261
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents... Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. The company also develops faecal calprotectin immunoassay turbo that offers results of calprotectin concentration in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay turbo, which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. Gentian Diagnostics ASA was founded in 2001 and is headquartered in Moss, Norway.
Cena akcji
$4.07
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$62.87M
Zmiana (1 dzień)
3.19%
Zmiana (1 rok)
-28.25%
Kraj
NO
Handel Gentian Diagnostics AS (GENT)

Kategoria

Cena GENT z kapitalizacją rynkową B
Gentian Diagnostics AS Gentian Diagnostics AS
GENT
$4.07
Kapitalizacja rynkowa Gentian Diagnostics AS(GENT)
Kapitalizacja rynkowa: $62.87M
Na dzień August 2026 spółka Gentian Diagnostics AS ma kapitalizację rynkową wynoszącą $62.87M. Według naszych danych, czyni to Gentian Diagnostics AS 24261st najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Gentian Diagnostics AS od 2016 do 2026
GENT w porównaniu do 5 najpopularniejszych stocks
Cena za GENT Aktywa B Kapitalizacja rynkowa B Wyniki
Gentian Diagnostics AS Gentian Diagnostics AS
$337,119 $62.87M
$5.211T +8,289,352.54%
Gentian Diagnostics AS Gentian Diagnostics AS
$294,125 $62.87M
$4.547T +7,232,171.57%
Gentian Diagnostics AS Gentian Diagnostics AS
$269,267 $62.87M
$4.162T +6,620,933.30%
Gentian Diagnostics AS Gentian Diagnostics AS
$232,414 $62.87M
$3.593T +5,714,764.72%
Gentian Diagnostics AS Gentian Diagnostics AS
$180,667 $62.87M
$2.793T +4,442,347.62%